Alembic
Alembic Limited is a Vadodara, India-based conglomerate founded in 1907 that manufactures fermentation and chemistry-based Active Pharmaceutical Ingredients, develops residential and commercial real estate via subsidiary Alembic City Limited, and operates 16 MW of co-generation and wind power capacity.
- Company typePublic
- Founded1907
- HeadquartersVadodara, India
- Headcount5,001–10,000
- GTM typeB2B
- OfferingHardware or Manufacturing
What Alembic does
Alembic Limited is a Vadodara-headquartered Indian public limited company incorporated in 1907 (CIN: L26100GJ1907PLC000033), listed on BSE (506235) and NSE (ALEMBICLTD). It operates as a diversified holding-style conglomerate with three distinct business segments: Pharmaceuticals (manufacturing and marketing of fermentation and chemistry-based Active Pharmaceutical Ingredients with R&D activity at Vadodara), Real Estate (construction of residential and commercial projects, project management, marketing consultancy, and commercial property leasing — operated through wholly-owned subsidiary Alembic City Limited), and Power Assets (co-generation plants totaling 11 MW plus four windmills totaling 5 MW).
The company's pharmaceutical segment is its core revenue contributor, producing APIs for the pharmaceutical industry via direct B2B sales with a domestic-India geographic scope. Manufacturing and R&D operations are concentrated at the Vadodara facility on Alembic Road. Capital intensity is a defining feature: 16 MW of captive power capacity supports manufacturing economics, and the firm also leases commercial real estate to multiple tenants.
Revenue generation is split across the three segments with no disclosed pricing transparency. Recent quarterly performance shows Rs 60.04 crore in Q4 FY26 (revenue) and Rs 74.34 crore in Q3 FY26, with profitability under pressure (Q4 FY26 consolidated net profit of Rs 9.61 crore, down 59.53% YoY). The Amin family, through Nirayu Limited (59.27% stake), controls 67.09% of equity via promoter holdings, leaving 32.91% with public shareholders including SBI Small Cap Fund (5.84%). Alembic Limited is distinct from its associated company Alembic Pharmaceuticals Limited, in which it holds a minority stake — a structural point that affects how the entity's standalone economics should be read versus group-wide financials.
Alembic firmographics
Firmographics- Name
- Alembic
- Legal name
- Alembic Limited
- Website
- https://alembiclimited.com
- Company type
- Public
- Founded year
- 1907
- Operating status
- Operating
- Headcount range
- 5,001–10,000 employees
- Short description
- Alembic Limited is a Vadodara, India-based conglomerate founded in 1907 that manufactures fermentation and chemistry-based Active Pharmaceutical Ingredients, develops residential and commercial real estate via subsidiary Alembic City Limited, and operates 16 MW of co-generation and wind power capacity.
- Ownership category
- akta.pro rank
Alembic industry classification
Industry- Product category
- Pharmaceutical API Manufacturing
- NAICS
- Pharmaceutical and Medicine Manufacturing (3254), Pharmaceutical and Medicine Manufacturing (32541)
- SIC
- Medicinal Chemicals & Botanical Products (2833), Industrial Organic Chemicals (2860)
- akta.pro primary industry
- Small-Molecule API Commercial Manufacturing (HLAGAHAB)
- akta.pro secondary industry
- Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC) (HLAGAHAM)
Keywords
Where Alembic is headquartered
LocationHeadquarters
- HQ city
- Vadodara
- HQ country
- India
- HQ region
- Asia
Offices1 record
Markets served
Alembic business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Technology or R&D, Supply Chain, Infrastructure, Marketing or Sales
Revenue model
- Pharmaceuticals (API): Manufacturing and marketing of fermentation and chemistry based Active Pharmaceuticals Ingredients (API) with Research and Development activities at Vadodara facility.
- Real Estate: Construction of residential and commercial real estate projects, project management and marketing consultancy. The company also gives commercial properties on lease to various tenants.
- Power Generation: Power generation through co-generation plants (11 MW total) and wind power (4 windmills of 5 MW total capacity).
Distribution channels1 record
Alembic product offering
Product offeringCore offering
Alembic Limited manufactures and markets fermentation and chemistry-based Active Pharmaceutical Ingredients (APIs) supported by in-house R&D at its Vadodara facility, with a diversified portfolio that also includes construction of residential and commercial real estate projects (plus leasing of commercial properties) and power generation through co-generation (11 MW) and wind power (5 MW across four windmills).
Product overview
Alembic Limited is a diversified Indian conglomerate with three distinct business segments operating as separate product lines rather than a unified platform. The company's core operations include: (1) Pharmaceuticals - manufacturing and marketing of fermentation and chemistry-based Active Pharmaceuticals Ingredients (API) with R&D capabilities at Vadodara; (2) Real Estate - construction of residential and commercial projects with property management and marketing consultancy services, plus commercial property leasing; and (3) Power Assets - co-generation plants (11 MW total) and wind power generation through 4 windmills (5 MW total). The company does not offer a software platform or integrated product suite.
Differentiator
Problem solved
Functional benefit
Products and services
- Pharmaceuticals (Active Pharmaceutical Ingredients)
- Real Estate (Residential and Commercial)
- Co-Generation Power
- Wind Power
Companies that use Alembic
Customer profileSegments1 record
Ideal customer profiles2 records
Alembic technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Alembic partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered minor and core.
- Bharat TaximinorBharat Taxi partnered with Alembic Foundation's #ForHerWithHer initiative to provide pink auto-rickshaw drivers access to a larger customer base, digital payment systems, and improved safety features. The platform operates a zero-commission model.
- MUFG Intime India Private LimitedcoreRegistrar and Transfer Agent for Alembic Limited. Located at 'Geetakunj', 1 Bhakti Nagar Society, Behind ABS Tower, Old Padra Road, Vadodara – 390 015, Gujarat.
Scale indicators5 records
Recent moves9 records
Expansion highlights4 records
Alembic competitors and assessment
Company assessmentBroad incumbents
- NATCO Pharma: Indian pharmaceutical company combining API manufacturing with branded and generic finished formulations, particularly in oncology and niche therapeutic areas. Comparable given its API+formulations integrated model serving regulated and emerging markets.
- Aurobindo Pharma: Large Indian integrated pharmaceutical company with significant API manufacturing across fermentation and chemistry platforms serving global regulated markets. Comparable due to overlapping API manufacturing model, though much larger in scale and broader in finished dosage forms.
- Piramal Pharma: Indian-headquartered global pharmaceutical company with significant API and contract manufacturing capabilities across multiple therapeutic areas. Comparable due to API manufacturing overlap and global customer reach, though broader in finished dosage offerings.
Direct peers
- Neuland Laboratories: Indian contract development and manufacturing organization (CDMO) focused on APIs and intermediates with chemistry-focused capabilities. Comparable to Alembic's chemistry-based API manufacturing model and similar mid-tier positioning in global API supply.
- Laurus Labs: Indian API and intermediates manufacturer with strong chemistry-based synthesis capabilities serving generic and antiretroviral markets. Directly comparable as a mid-scale Indian API specialist competing in similar therapeutic categories and chemistry platforms.
- Divi's Laboratories: Indian pure-play API manufacturer focused on fermentation and chemistry-based APIs for global generics and custom synthesis. Most directly comparable to Alembic Limited given shared fermentation/chemistry capabilities and API-focused customer base.
- Granules India: Indian pharmaceutical manufacturer with significant API and intermediate capabilities feeding its formulations business. Comparable as a vertically integrated API+formulations Indian peer with similar fermentation/chemistry production.
- Suven Pharmaceuticals: Indian API and contract research services company focused on central nervous system and other therapeutic categories. Comparable as a mid-tier Indian API manufacturer with chemistry-based capabilities targeting global pharma clients.
Emerging players
- Sai Life Sciences: Indian API CDMO offering contract development and manufacturing services for global pharma and biotech customers. Comparable given shared API manufacturing focus and India-based cost structure serving regulated market customers.
- MSN Laboratories: Privately-held Indian pharmaceutical manufacturer with API production capabilities and growing formulations business. Comparable as another India-based API player with chemistry manufacturing serving global generic markets.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Alembic social profiles
Digital presenceAlembic financial estimates
Financial estimateRevenue estimate
Valuation estimate
Alembic leadership team
Management profileNumber of profiles
Profiles10 records
Alembic subsidiaries and ownership
Company hierarchySubsidiaries2 records
Alembic funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Alembic M&A and investment
M&A and investmentM&A1 record
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Alembic
What does Alembic do?
Alembic Limited manufactures and markets fermentation and chemistry-based Active Pharmaceutical Ingredients (APIs) supported by in-house R&D at its Vadodara facility, with a diversified portfolio that also includes construction of residential and commercial real estate projects (plus leasing of commercial properties) and power generation through co-generation (11 MW) and wind power (5 MW across four windmills).
Is Alembic a public or private company?
Alembic is a public company. It is classified as public and is currently operating.
When was Alembic founded?
Alembic was founded in 1907. It employs 5,001 to 10,000 people.
Where is Alembic based?
Alembic is headquartered in Vadodara, India, in the Asia region.
How does Alembic make money?
Three revenue lines are on record. Pharmaceuticals (API) is the primary driver. The others are real Estate and power Generation.
Who are Alembic's main competitors?
Broad incumbents on record are NATCO Pharma, Aurobindo Pharma and Piramal Pharma. Direct peers are Neuland Laboratories, Laurus Labs, Divi's Laboratories, Granules India and Suven Pharmaceuticals. Emerging players are Sai Life Sciences and MSN Laboratories.
Does Alembic have an API?
No public API is recorded for Alembic.
What industry is Alembic in?
Alembic's product category is Pharmaceutical API Manufacturing. Its primary akta.pro industry code is HLAGAHAB, Small-Molecule API Commercial Manufacturing, with a secondary code of HLAGAHAM, Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC). Its NAICS code is 3254 and its SIC code is 2833.